Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - orbifloxacin - oral tablet - orbifloxacin antibiotic active 6.25 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - acinetobacter spp. | enterobacter spp. | enterococcus faecalis | escherichia coli (e. coli) | klebsiella pneumoniae | pasteurella multocida | proteus mirabilis | pseudomonas spp. | staphylococcus intermedius | streptococcus - hemolytic group g | deep pyodermas | fowl cholera | including b-lactamase producin | including secondary invaders | seborrhoeic dermatitis

Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

advanced feeds pty ltd - trimethoprim; sulfadimidine - oral powder, pre-mix - trimethoprim pyrimidine active 90.0 mg/g; sulfadimidine sulfanyl active 450.0 mg/g - antibiotic & related - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - actinobacillus equuli | escherichia coli (e. coli) | pasteurella spp. | salmonella | staphylococcus aureus | staphylococcus intermedius | streptococcus equi var equi | streptococcus zooepidemicus | deep pyodermas | including b-lactamase producin | including secondary invaders | pasterellosis | pasteurellosis | salmonellosis | seborrhoeic dermatitis

Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

advanced feeds pty ltd - bromhexine hydrochloride; trimethoprim; sulfadimidine - oral powder, pre-mix - bromhexine hydrochloride guanidine active 9.0 mg/g; trimethoprim pyrimidine active 90.0 mg/g; sulfadimidine sulfanyl active 450.0 mg/g - antibiotic & related - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - actinobacillus equuli | escherichia coli (e. coli) | infections of the respiratory tract | pasteurella spp. | salmonella | staphylococcus aureus | staphylococcus intermedius | streptococcus equi var equi | streptococcus zooepidemicus | acute respiratory infections | bronchiseptica | bronchitis | deep pyodermas | including b-lactamase producin | including secondary invaders | pasterellosis | pasteurellosis | pharyngitis | pneumonia | salmonellosis | seborrhoeic dermatitis | tonsillitis

Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dermcare-vet pty. ltd. - chlorhexidine gluconate; miconazole nitrate - topical solution/suspension - chlorhexidine gluconate guanidine active 20.0 g/l; miconazole nitrate triazole active 20.0 g/l - dermatological preps. - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - bacterial dermatitis | dermatophyte infection (ringworm) | fungal infection | keratolytic or cleaning agent | malassezia pachydermatis | ringworm | seborrhoea (inflammatory forms) | staphylococcus intermedius | biotin deficiency | brittle hoof | cleansing agents | coat appearance | conditioning | conjunctivitis | cracked hoof | deep pyodermas | dry skin | flaking | galls | grooming aids | hoof conditioning | hoof moisturising | hopple chafes | including secondary invaders | itching | laminitis | moisturising | pityrosporum pachydermatis | pliability | psoriasis | scratches | seborrhoeic dermatitis | skin cleanser | trichophyton mentagrophytes | wart removal

Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - enrofloxacin - parenteral liquid/solution/suspension - enrofloxacin antibiotic active 50.0 mg/ml - antibiotic & related - animal - exotic | cat | dog | avian species | bitch | castrate | cat - queen | cat - tom | exotic animals | kitten | puppy | rep - antibiotics - oral, parenteral | infections of the respiratory tract | infections of the urinary tracts | staphylococcus intermedius | wound infections | abscesses | acute respiratory infections | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | avian mycoplasmas | bronchiseptica | bronchitis | clavulanic acid sensitive | coccidiosis | coryza | crd | deep pyodermas | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | group d streptococcus | hypermotility | including secondary invaders | infected wounds | infections | klebsiella spp. | lactating | mastitis | pharyngitis | pneumonia | proteus spp. | protozoal infections | pseudomonas aeruginosa | pyometra | salmonellosis | seborrhoeic dermatitis | sinusitis | staphylococcus spp. | systemic bacterial infection | tonsillitis

Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - enrofloxacin - oral solution/suspension - enrofloxacin antibiotic active 25.0 mg/ml - antibiotic & related - animal - exotic | cat | dog | avian species | bitch | castrate | cat - queen | cat - tom | exotic animals | kitten | puppy | rep - antibiotics - oral, parenteral | infections of the respiratory tract | infections of the urinary tracts | staphylococcus intermedius | wound infections | abscesses | acute respiratory infections | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | avian mycoplasmas | bronchiseptica | bronchitis | clavulanic acid sensitive | coccidiosis | coryza | crd | deep pyodermas | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | group d streptococcus | hypermotility | including secondary invaders | infected wounds | infections | klebsiella spp. | lactating | mastitis | pharyngitis | pneumonia | proteus spp. | protozoal infections | pseudomonas aeruginosa | pyometra | salmonellosis | seborrhoeic dermatitis | sinusitis | staphylococcus spp. | systemic bacterial infection | tonsillitis

Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dermcare-vet pty. ltd. - chlorhexidine gluconate; selenium sulfide; miconazole nitrate - shampoo - chlorhexidine gluconate guanidine active 20.0 g/l; selenium sulfide mineral-selenium active 2.5 g/l; miconazole nitrate triazole active 20.0 g/l - dermatological preps. - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - malassezia pachydermatis | staphylococcus intermedius | treatment of dermatophyte infection | deep pyodermas | including secondary invaders | microsporum canis | microsporum gypseum | pityrosporum pachydermatis | seborrhoeic dermatitis | trichophyton mentagrophytes

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

bayer new zealand limited - moxifloxacin hydrochloride 436.8mg equivalent to 400 mg moxifloxacin - film coated tablet - 400 mg - active: moxifloxacin hydrochloride 436.8mg equivalent to 400 mg moxifloxacin excipient: croscarmellose sodium hypromellose iron oxide red lactose monohydrate macrogol 4000 magnesium stearate powdered cellulose titanium dioxide - avelox tablets and solution for infusion is indicated for the treatment of the following bacterial infections caused by susceptible strains: · bronchitis (acute exacerbations of chronic bronchitis)

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

bayer new zealand limited - moxifloxacin hydrochloride 436.8mg equivalent to 400 mg moxifloxacin - solution for infusion - 400 mg - active: moxifloxacin hydrochloride 436.8mg equivalent to 400 mg moxifloxacin excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - avelox tablets and solution for infusion is indicated for the treatment of the following bacterial infections caused by susceptible strains: · complicated intra-abdominal infections including polymicrobial infections such as abscesses

Israel - anglès - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - tigecycline - powder for solution for infusion - tigecycline 50 mg/dose - tigecycline - tigecycline - tygacil is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below for patients 18 years of age and older:complicated skin and skin structure infections:complicated skin and skin structure infections caused by escherichia coli, enterococcus faecalis (vancomycin-susceptible isolates ), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus agalactiae, streptococcus anginosus grp. (includes s. anginosus, s. intermedius, and s. constellatus), streptococcus pyogenes, enterobacter cloacae, klebsiella pneumoniae, and bacteroides fragilis .complicated intra-abdominal infections:complicated intra-abdominal infections caused by citrobacter freundii, enterobacter cloacae, escherichia coli, klebsiella oxytoca, klebsiella pneumoniae, enterococcus faecalis (vancomycin-susceptible isolates), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus anginosus grp. (includes s. anginosus, s. intermedius, and s. constellatus), bacteroides fragilis, bacteroides thetaiotaomicron, bacteroides uniformis, bacteroides vulgatus, clostridium perfringens, and peptostreptococcus micros.community-acquired bacterial pneumonia:community-acquired bacterial pneumonia caused by streptococcus pneumoniae (penicillin susceptible isolates), including cases with concurrent bacteremia, haemophilus influenzae (beta-lactamase negative isolates), and legionella pneumophila.